Literature DB >> 7494280

Antibody-forming cell response to virus challenge in mice immunized with DNA encoding the influenza virus hemagglutinin.

D M Justewicz1, M J Morin, H L Robinson, R G Webster.   

Abstract

Immunization of mice with DNA encoding the influenza virus hemagglutinin (HA) affords complete protection against lethal influenza virus infection and the means to investigate the mechanisms of B-cell responsiveness to virus challenge. Using a single-cell enzyme-linked immunospot assay, we sought to determine the localization of HA-specific antibody-forming cells (AFCs) during the development of humoral immunity in mice given HA DNA vaccine by gene gun. At 33 days postvaccination, populations of AFCs were maintained in the spleen and bone marrow. In response to lethal challenge with influenza virus, the AFCs became localized at the site of antigenic challenge, i.e., within the draining lymph nodes of the lung compartment. Immunoglobulin G (IgG)- and IgA-producing AFCs were detected in lymph nodes of the upper and lower respiratory tracts, underscoring their importance in clearing virus from the lungs. Response to challenge required competent CD4+ T cells, without which no AFCs were generated, even those producing IgM. By contrast, in mice vaccinated with an HA-containing subunit vaccine, fewer AFCs were generated in response to challenge, and these animals were less capable of resisting infection. Our findings demonstrate the comparable localization of AFCs in response to challenge in mice vaccinated with either HA DNA or live virus. Moreover, the former strategy generates both IgG- and IgA-producing plasma cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494280      PMCID: PMC189712     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

Review 1.  Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.

Authors:  T A Springer
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

2.  Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.

Authors:  H L Robinson; L A Hunt; R G Webster
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

3.  Free recirculation of memory B cells versus antigen-dependent differentiation to antibody-forming cells.

Authors:  M F Bachmann; T M Kündig; B Odermatt; H Hengartner; R M Zinkernagel
Journal:  J Immunol       Date:  1994-10-15       Impact factor: 5.422

4.  Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity.

Authors:  S Liang; K Mozdzanowska; G Palladino; W Gerhard
Journal:  J Immunol       Date:  1994-02-15       Impact factor: 5.422

5.  Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization.

Authors:  M D Eisenbraun; D H Fuller; J R Haynes
Journal:  DNA Cell Biol       Date:  1993-11       Impact factor: 3.311

6.  Mice lacking CD8+ T cells develop greater numbers of IgA-producing cells in response to a respiratory virus infection.

Authors:  L Hyland; S Hou; C Coleclough; T Takimoto; P C Doherty
Journal:  Virology       Date:  1994-10       Impact factor: 3.616

7.  Respiratory virus infection of mice provokes a permanent humoral immune response.

Authors:  L Hyland; M Sangster; R Sealy; C Coleclough
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses.

Authors:  E Raz; D A Carson; S E Parker; T B Parr; A M Abai; G Aichinger; S H Gromkowski; M Singh; D Lew; M A Yankauckas
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

9.  How many specific B cells are needed to protect against a virus?

Authors:  M F Bachmann; T M Kündig; C P Kalberer; H Hengartner; R M Zinkernagel
Journal:  J Immunol       Date:  1994-05-01       Impact factor: 5.422

10.  Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection.

Authors:  M B Graham; V L Braciale; T J Braciale
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  15 in total

1.  Humoral and cellular immunogenecity of DNA vaccine based on hepatitis B core gene in rhesus monkeys.

Authors:  Z H Huang; H Zhuang; S Lu; R H Guo; G M Xu; J Cai; W F Zhu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response.

Authors:  P J Lewis; L A Babiuk
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

3.  Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.

Authors:  Shixia Wang; Jessica Taaffe; Christopher Parker; Alicia Solórzano; Hong Cao; Adolfo García-Sastre; Shan Lu
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

4.  Role of different lymphoid tissues in the initiation and maintenance of DNA-raised antibody responses to the influenza virus H1 glycoprotein.

Authors:  C M Boyle; M Morin; R G Webster; H L Robinson
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

Review 5.  Cross-protection against drifted influenza viruses: options offered by adjuvanted and intradermal vaccines.

Authors:  Andrea Orsi; Filippo Ansaldi; Daniela de Florentiis; Antonella Ceravolo; Valentina Parodi; Paola Canepa; Martina Coppelli; Giancarlo Icardi; Paolo Durando
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

Review 6.  Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine.

Authors:  Lisa E Pomeranz; Ashley E Reynolds; Christoph J Hengartner
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

Review 7.  The Multifaceted B Cell Response to Influenza Virus.

Authors:  Jonathan H Lam; Nicole Baumgarth
Journal:  J Immunol       Date:  2019-01-15       Impact factor: 5.422

8.  Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses.

Authors:  Lu Zhang; Na Jia; Jun Li; Yaping Han; Wuchun Cao; Shixia Wang; Zuhu Huang; Shan Lu
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

9.  Enhancement of DNA Vaccine-induced Immune Responses by Influenza Virus NP Gene.

Authors:  So Young Choi; You Suk Suh; Jae Ho Cho; Hyun Tak Jin; Jun Chang; Young Chul Sung
Journal:  Immune Netw       Date:  2009-10-30       Impact factor: 6.303

10.  GM-CSF increases mucosal and systemic immunogenicity of an H1N1 influenza DNA vaccine administered into the epidermis of non-human primates.

Authors:  Peter T Loudon; Eric J Yager; Debbie T Lynch; Amithi Narendran; Cristy Stagnar; Anthony M Franchini; James T Fuller; Phil A White; Julia Nyuandi; Clayton A Wiley; Michael Murphey-Corb; Deborah H Fuller
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.